SCHEMBL9979779

SCHEMBL9979779

Oc1cc2cc3cc(O)c(O)cc3nc2cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.42
PDGFRB P09619 2/20 0.42
PDGFRA P16234 2/20 0.42
TERT O14746 2/20 0.39
MAPT P10636 5/20 0.38
SNCA P37840 1/20 0.38
MYC P01106 1/20 0.37
MAX P61244 1/20 0.37
ACHE P22303 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
F2 P00734 1/20 0.36
LMNA P02545 1/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
MAOA P21397 1/20 0.36
DRD1 P21728 1/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15581106 0.85 KDM4E (0.46) EGFRPDGFRBPDGFRATERTMAPT
SCHEMBL9979780 0.83 MAPT (0.46) EGFRPDGFRBPDGFRAMAPTSNCA
SCHEMBL9979789 0.82 EGFR (0.36) EGFRPDGFRBPDGFRAMAPTSNCA
SCHEMBL9979783 0.78 EGFR (0.33) EGFRPDGFRBPDGFRAMAPTALDH1A1
SCHEMBL9979788 0.78 EGFR (0.34) EGFRPDGFRBPDGFRAMAPTSNCA
SCHEMBL9979787 0.77 KDM4E (0.32) EGFRPDGFRBPDGFRATERTALDH1A1
SCHEMBL31255815 0.75 LCK (0.42) MAPTACHEKMT2AMEN1LMNA
SCHEMBL5358508 0.75 LCK (0.42) MAPTACHEKMT2AMEN1LMNA
SCHEMBL8320612 0.75 EGFR (0.36) EGFRPDGFRBPDGFRAMAPTSNCA
SCHEMBL107294 0.75 PTPN22 (0.38) EGFRPDGFRBPDGFRAMAPTSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9978474-B2 Conductive open frameworks THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-05-22 US disclosed
US-20160247593-A1 CONDUCTIVE OPEN FRAMEWORKS UNITED STATES DEPARTMENT OF ENERGY 2016-08-25 US disclosed
US-9269473-B2 Conductive open frameworks THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-02-23 US disclosed
WO-2012082213-A2 CONDUCTIVE OPEN FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160247593-A1 CONDUCTIVE OPEN FRAMEWORKS GJB2, OR10J3, EPCAM EGFR 3295/4885PDGFRB 3652/4885PDGFRA 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.